1. Home
  2. OGN vs CBZ Comparison

OGN vs CBZ Comparison

Compare OGN & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CBZ
  • Stock Information
  • Founded
  • OGN 1923
  • CBZ 1987
  • Country
  • OGN United States
  • CBZ United States
  • Employees
  • OGN N/A
  • CBZ 6700
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CBZ Business Services
  • Sector
  • OGN Health Care
  • CBZ Consumer Discretionary
  • Exchange
  • OGN Nasdaq
  • CBZ Nasdaq
  • Market Cap
  • OGN 4.0B
  • CBZ 3.9B
  • IPO Year
  • OGN N/A
  • CBZ N/A
  • Fundamental
  • Price
  • OGN $15.45
  • CBZ $72.63
  • Analyst Decision
  • OGN Hold
  • CBZ Strong Buy
  • Analyst Count
  • OGN 5
  • CBZ 1
  • Target Price
  • OGN $20.80
  • CBZ $86.00
  • AVG Volume (30 Days)
  • OGN 3.5M
  • CBZ 373.9K
  • Earning Date
  • OGN 05-01-2025
  • CBZ 04-24-2025
  • Dividend Yield
  • OGN 7.25%
  • CBZ N/A
  • EPS Growth
  • OGN N/A
  • CBZ N/A
  • EPS
  • OGN 3.33
  • CBZ 0.78
  • Revenue
  • OGN $6,403,000,000.00
  • CBZ $1,813,472,000.00
  • Revenue This Year
  • OGN N/A
  • CBZ $23.02
  • Revenue Next Year
  • OGN $1.70
  • CBZ $24.88
  • P/E Ratio
  • OGN $4.64
  • CBZ $93.14
  • Revenue Growth
  • OGN 2.24
  • CBZ 13.97
  • 52 Week Low
  • OGN $13.87
  • CBZ $62.66
  • 52 Week High
  • OGN $23.10
  • CBZ $90.13
  • Technical
  • Relative Strength Index (RSI)
  • OGN 52.52
  • CBZ 24.48
  • Support Level
  • OGN $14.13
  • CBZ $83.04
  • Resistance Level
  • OGN $16.18
  • CBZ $90.13
  • Average True Range (ATR)
  • OGN 0.58
  • CBZ 2.74
  • MACD
  • OGN -0.02
  • CBZ -1.48
  • Stochastic Oscillator
  • OGN 64.48
  • CBZ 9.44

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.

Share on Social Networks: